1	Peripheral	peripheral	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	lymphocytes	lymphocyte	_	_	_	_	_	_	_
4	from	from	_	_	_	_	_	_	_
5	women	woman	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	breast	breast	_	_	_	_	_	_	_
8	cancer	cancer	_	_	_	_	_	_	_
9	exhibit	exhibit	_	_	_	_	_	_	_
10	abnormal	abnormal	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	expression	expression	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	several	several	_	_	_	_	_	_	_
15	signaling	signal	_	_	_	_	_	_	_
16	molecules	molecule	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	examined	examine	_	_	_	_	_	_	_
3	signaling	signal	_	_	_	_	_	_	_
4	molecules	molecule	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	peripheral	peripheral	_	_	_	_	_	_	_
7	blood	blood	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	lymphocytes	lymphocyte	_	_	_	_	_	_	_
10	obtained	obtain	_	_	_	_	_	_	_
11	from	from	_	_	_	_	_	_	_
12	women	woman	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	breast	breast	_	_	_	_	_	_	_
15	cancer	cancer	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	6	6	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	14	14	_	_	_	_	_	_	_
5	patients	patient	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	lymphocytes	lymphocyte	_	_	_	_	_	_	_
9	displayed	display	_	_	_	_	_	_	_
10	an	an	_	_	_	_	_	_	_
11	impaired	impaired	_	_	_	_	_	_	_
12	ability	ability	_	_	_	_	_	_	_
13	to	to	_	_	_	_	_	_	_
14	translocate	translocate	_	_	_	_	_	_	_
15	NFeB	NFeB	_	_	_	_	_	_	_
16	p65	p65	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	Rel-A	Rel-A	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	following	follow	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	by	by	_	_	_	_	_	_	_
23	anti-CD3	anti-cd3	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	IL-2	il-2	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	observation	observation	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	made	make	_	_	_	_	_	_	_
5	despite	despite	_	_	_	_	_	_	_
6	normal	normal	_	_	_	_	_	_	_
7	cytoplasmic	cytoplasmic	_	_	_	_	_	_	_
8	levels	level	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	Rel-A	Rel-A	_	_	_	_	_	_	_
12	protein	protein	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	detected	detect	_	_	_	_	_	_	_
4	abnormally	abnormally	_	_	_	_	_	_	_
5	low	low	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	the	the	_	_	_	_	_	_	_
9	signaling	signal	_	_	_	_	_	_	_
10	molecules	molecule	_	_	_	_	_	_	_
11	T-cell	t-cell	_	_	_	_	_	_	_
12	receptor	receptor	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	TCR)-zeta	TCR)-zeta	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	ZAP-70	zap-70	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	p56lck	p56lck	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	4	4	_	_	_	_	_	_	_
21	of	of	_	_	_	_	_	_	_
22	14	14	_	_	_	_	_	_	_
23	breast	breast	_	_	_	_	_	_	_
24	cancer	cancer	_	_	_	_	_	_	_
25	patients	patient	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	i.e.	i.e.	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	defects	defect	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	T-cell	t-cell	_	_	_	_	_	_	_
32	signaling	signal	_	_	_	_	_	_	_
33	molecules	molecule	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	T	t	_	_	_	_	_	_	_
2	lymphocytes	lymphocyte	_	_	_	_	_	_	_
3	from	from	_	_	_	_	_	_	_
4	6	6	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	14	14	_	_	_	_	_	_	_
8	patients	patient	_	_	_	_	_	_	_
9	also	also	_	_	_	_	_	_	_
10	exhibited	exhibit	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	increased	increase	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	dual	dual	_	_	_	_	_	_	_
17	specificity	specificity	_	_	_	_	_	_	_
18	phosphatase	phosphatase	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	map	map	_	_	_	_	_	_	_
21	kinase	kinase	_	_	_	_	_	_	_
22	phosphatase-1	phosphatase-1	_	_	_	_	_	_	_
23	(	(	_	_	_	_	_	_	_
24	MKP-1	mkp-1	_	_	_	_	_	_	_
25	)	)	_	_	_	_	_	_	_
26	.	.	_	_	_	_	_	_	_

1	MKP-1	mkp-1	_	_	_	_	_	_	_
2	inactivates	inactivate	_	_	_	_	_	_	_
3	MAP	MAP	_	_	_	_	_	_	_
4	kinase	kinase	_	_	_	_	_	_	_
5	and	and	_	_	_	_	_	_	_
6	therefore	therefore	_	_	_	_	_	_	_
7	may	may	_	_	_	_	_	_	_
8	interfere	interfere	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	activation	activation	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	c-jun	c-jun	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	c-fos	c-fos	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Abnormalities	abnormality	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	I	I	_	_	_	_	_	_	_
4	or	or	_	_	_	_	_	_	_
5	more	more	_	_	_	_	_	_	_
6	signaling	signal	_	_	_	_	_	_	_
7	molecules	molecule	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	found	find	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	9	9	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	14	14	_	_	_	_	_	_	_
14	patients	patient	_	_	_	_	_	_	_
15	;	;	_	_	_	_	_	_	_
16	however	however	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	only	only	_	_	_	_	_	_	_
19	3	3	_	_	_	_	_	_	_
20	patients	patient	_	_	_	_	_	_	_
21	had	have	_	_	_	_	_	_	_
22	T	t	_	_	_	_	_	_	_
23	cells	cell	_	_	_	_	_	_	_
24	that	that	_	_	_	_	_	_	_
25	exhibited	exhibit	_	_	_	_	_	_	_
26	all	all	_	_	_	_	_	_	_
27	5	5	_	_	_	_	_	_	_
28	defects	defect	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	implications	implication	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	the	the	_	_	_	_	_	_	_
7	detection	detection	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	potentially	potentially	_	_	_	_	_	_	_
10	dysfunctional	dysfunctional	_	_	_	_	_	_	_
11	T	t	_	_	_	_	_	_	_
12	cells	cell	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	patients	patient	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	cancer	cancer	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	For	for	_	_	_	_	_	_	_
2	example	example	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	analysis	analysis	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	only	only	_	_	_	_	_	_	_
8	1	1	_	_	_	_	_	_	_
9	signaling	signal	_	_	_	_	_	_	_
10	molecule	molecule	_	_	_	_	_	_	_
11	may	may	_	_	_	_	_	_	_
12	allow	allow	_	_	_	_	_	_	_
13	patients	patient	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	significant	significant	_	_	_	_	_	_	_
16	defects	defect	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	T-cell	T-cell	_	_	_	_	_	_	_
19	signaling	signaling	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	go	go	_	_	_	_	_	_	_
22	unnoticed	unnoticed	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Finally	finally	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	despite	despite	_	_	_	_	_	_	_
4	impaired	impaired	_	_	_	_	_	_	_
5	Rel-A	Rel-A	_	_	_	_	_	_	_
6	translocation	translocation	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	T	t	_	_	_	_	_	_	_
9	cells	cell	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	capable	capable	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	transcribing	transcribe	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Impairments	impairment	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	translocation	translocation	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	Rel-B	Rel-B	_	_	_	_	_	_	_
7	and	and	_	_	_	_	_	_	_
8	c-Rel	c-rel	_	_	_	_	_	_	_
9	further	further	_	_	_	_	_	_	_
10	suggest	suggest	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	NFKB	NFKB	_	_	_	_	_	_	_
14	family	family	_	_	_	_	_	_	_
15	members	member	_	_	_	_	_	_	_
16	Rel-A	Rel-A	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	Rel-B	Rel-B	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	c-Rel	c-rel	_	_	_	_	_	_	_
21	are	be	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	required	require	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	transcription	transcription	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	IL-2	il-2	_	_	_	_	_	_	_
29	in	in	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	peripheral	peripheral	_	_	_	_	_	_	_
32	T	t	_	_	_	_	_	_	_
33	lymphocytes	lymphocyte	_	_	_	_	_	_	_
34	of	of	_	_	_	_	_	_	_
35	patients	patient	_	_	_	_	_	_	_
36	with	with	_	_	_	_	_	_	_
37	breast	breast	_	_	_	_	_	_	_
38	cancer	cancer	_	_	_	_	_	_	_
39	.	.	_	_	_	_	_	_	_

